 Barbara Hammack
Concepts (77)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytochrome c Group | 5 | 2003 | 54 | 0.690 |
Why?
| | Cytochromes c | 4 | 2003 | 67 | 0.510 |
Why?
| | Saccharomyces cerevisiae Proteins | 4 | 2003 | 370 | 0.390 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2004 | 108 | 0.320 |
Why?
| | Guanidine | 5 | 2003 | 39 | 0.310 |
Why?
| | Protein Folding | 5 | 2003 | 310 | 0.300 |
Why?
| | Cerebrospinal Fluid Proteins | 1 | 2003 | 15 | 0.260 |
Why?
| | Cerebrospinal Fluid | 1 | 2004 | 99 | 0.260 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2004 | 65 | 0.250 |
Why?
| | Clinical Trials Data Monitoring Committees | 1 | 2021 | 6 | 0.220 |
Why?
| | Yeasts | 1 | 2001 | 60 | 0.220 |
Why?
| | Multiple Sclerosis | 1 | 2003 | 334 | 0.190 |
Why?
| | Hydrochloric Acid | 1 | 1998 | 13 | 0.180 |
Why?
| | Proteomics | 1 | 2004 | 774 | 0.180 |
Why?
| | Patient Safety | 1 | 2021 | 309 | 0.170 |
Why?
| | Histidine | 4 | 2003 | 69 | 0.130 |
Why?
| | Protein Denaturation | 4 | 2003 | 118 | 0.130 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2004 | 148 | 0.120 |
Why?
| | Heme | 3 | 2001 | 40 | 0.110 |
Why?
| | Circular Dichroism | 3 | 2001 | 178 | 0.110 |
Why?
| | Thermodynamics | 4 | 2003 | 439 | 0.110 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2001 | 582 | 0.100 |
Why?
| | Enzyme Stability | 3 | 2003 | 103 | 0.080 |
Why?
| | Neuralgia, Postherpetic | 1 | 2006 | 46 | 0.080 |
Why?
| | Valine | 1 | 2006 | 88 | 0.070 |
Why?
| | Acyclovir | 1 | 2006 | 114 | 0.070 |
Why?
| | Titrimetry | 2 | 2001 | 11 | 0.070 |
Why?
| | Peptide Mapping | 1 | 2004 | 72 | 0.070 |
Why?
| | Isoelectric Focusing | 1 | 2003 | 39 | 0.070 |
Why?
| | Salts | 1 | 2003 | 42 | 0.060 |
Why?
| | Albumins | 1 | 2003 | 102 | 0.060 |
Why?
| | Immunoglobulins | 1 | 2003 | 141 | 0.060 |
Why?
| | Central Nervous System Infections | 1 | 2003 | 40 | 0.060 |
Why?
| | Serine Endopeptidases | 1 | 2001 | 102 | 0.050 |
Why?
| | Protein Conformation | 2 | 2001 | 952 | 0.050 |
Why?
| | Acetylation | 1 | 2001 | 222 | 0.050 |
Why?
| | Vascular Diseases | 1 | 2003 | 229 | 0.050 |
Why?
| | Antiviral Agents | 1 | 2006 | 648 | 0.050 |
Why?
| | Research Personnel | 1 | 2021 | 146 | 0.050 |
Why?
| | Herpes Zoster | 1 | 2003 | 318 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 2 | 2003 | 528 | 0.050 |
Why?
| | Herpesvirus 3, Human | 1 | 2003 | 392 | 0.050 |
Why?
| | Static Electricity | 1 | 1998 | 117 | 0.040 |
Why?
| | Spectrum Analysis | 1 | 1998 | 91 | 0.040 |
Why?
| | Solvents | 1 | 1998 | 132 | 0.040 |
Why?
| | Methionine | 1 | 1998 | 158 | 0.040 |
Why?
| | Mutagenesis | 1 | 1998 | 182 | 0.040 |
Why?
| | Models, Molecular | 2 | 2003 | 1546 | 0.040 |
Why?
| | Molecular Structure | 1 | 1998 | 491 | 0.040 |
Why?
| | Protein Binding | 1 | 2001 | 2056 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2021 | 2940 | 0.030 |
Why?
| | Mutation | 1 | 2001 | 3403 | 0.030 |
Why?
| | Humans | 5 | 2021 | 115146 | 0.020 |
Why?
| | Middle Aged | 2 | 2006 | 28958 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2006 | 242 | 0.020 |
Why?
| | Subacute Sclerosing Panencephalitis | 1 | 2003 | 7 | 0.020 |
Why?
| | Isoleucine | 1 | 2003 | 12 | 0.020 |
Why?
| | Oligoclonal Bands | 1 | 2003 | 22 | 0.020 |
Why?
| | Administration, Oral | 1 | 2006 | 798 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2006 | 1006 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2003 | 287 | 0.010 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2003 | 388 | 0.010 |
Why?
| | Isoenzymes | 1 | 2003 | 356 | 0.010 |
Why?
| | Adult | 1 | 2004 | 32202 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 887 | 0.010 |
Why?
| | Female | 2 | 2006 | 63296 | 0.010 |
Why?
| | Biopolymers | 1 | 2000 | 32 | 0.010 |
Why?
| | Binding, Competitive | 1 | 2000 | 213 | 0.010 |
Why?
| | Ligands | 1 | 2000 | 518 | 0.010 |
Why?
| | Models, Chemical | 1 | 2000 | 297 | 0.010 |
Why?
| | Aged | 2 | 2006 | 20309 | 0.010 |
Why?
| | Kinetics | 1 | 2000 | 1759 | 0.010 |
Why?
| | Genetic Variation | 1 | 2000 | 825 | 0.010 |
Why?
| | Prospective Studies | 1 | 2006 | 6324 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2006 | 6845 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2006 | 9218 | 0.010 |
Why?
| | Male | 2 | 2006 | 60969 | 0.010 |
Why?
|
|
Hammack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Physical Neighbors People whose addresses are nearby this person. _
|